<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Ras-ERK pathway is frequently up-regulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed the clinical-pathological correlation of K-Ras mutation and phospho-ERK expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>K-Ras mutations were detected in only 32.5% (41/126) of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases, while <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were positive for phospho-ERK staining </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> with wild-typeK-Ras and low phospho-ERK expression had a significantly higher survival rate (log-rank P = 0.04) </plain></SENT>
<SENT sid="4" pm="."><plain>There were 9 cases of K-Ras mutation/low phospho-ERK diseases; 88.9% (8/9) of them were stage III/IV diseases </plain></SENT>
<SENT sid="5" pm="."><plain>High phospho-ERK expression was associated with a high stage and T status of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, yet combined K-Ras mutation/phospho-ERK expression analysis further increased the efficiency of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> prognosis </plain></SENT>
<SENT sid="6" pm="."><plain>Our results demonstrate that Ras-ERK pathway correlated closely with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, although <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with K-Ras mutations has a more aggressive phenotype; the mutation rate is not very high </plain></SENT>
<SENT sid="8" pm="."><plain>Phospho-ERK may be a useful marker in combination with K-Ras for improving the prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>